Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in ChinaYuankai Shi, Jingwen Wang, Lugui Qiu et al.|Journal of Hematology & Oncology|2017Cited by 256
Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cellsCuiying He, Lihong Liu|BMC Cancer|2022Cited by 8